EXCLUSIVE Cryoport Boosts Cold Chain Tech With New Shippers Designed For Delays And Rough Handling
| CYRX Stock | USD 7.16 0.11 1.51% |
Slightly above 62% of Cryoport's investor base is looking to short. The analysis of overall sentiment of trading Cryoport stock suggests that many investors are alarmed at this time. Cryoport's investing sentiment can be driven by a variety of factors including economic data, Cryoport's earnings reports, geopolitical events, and overall market trends.
Cryoport announced launch of MVE Biological Solutions new vapor shippers, offering improved safety and reliability for transporting sensitive biological materials at cryogenic temps. Stock closes lower by 4.83 percent at 7.290 on Monday.
Read at benzinga.com
 |
Cryoport Fundamental Analysis
We analyze Cryoport's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cryoport using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cryoport based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Cryoport is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Cryoport Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cryoport stock to make a market-neutral strategy. Peer analysis of Cryoport could also be used in its relative valuation, which is a method of valuing Cryoport by comparing valuation metrics with similar companies.
Peers
Cryoport Related Equities
| CDNA | CareDx | 3.11 | ||||
| FWRD | Forward Air | 2.27 | ||||
| NTRA | Natera | 1.48 | ||||
| GXO | GXO Logistics | 1.38 | ||||
| CHRW | CH Robinson | 0.82 | ||||
| BLFS | BioLife Solutions | 0.38 | ||||
| IRTC | IRhythm Technologies | 0.01 | ||||
| EXPD | Expeditors International | 0.61 | ||||
| ZTO | ZTO Express | 3.86 |
Additional Tools for Cryoport Stock Analysis
When running Cryoport's price analysis, check to measure Cryoport's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryoport is operating at the current time. Most of Cryoport's value examination focuses on studying past and present price action to predict the probability of Cryoport's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryoport's price. Additionally, you may evaluate how the addition of Cryoport to your portfolios can decrease your overall portfolio volatility.